|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.414
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.361
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.324
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.299
|
|
|
|
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000161 |
1 |
0.293
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.292
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.287
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.285
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.285
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.258
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.250
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.247
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.246
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.235
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.225
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.214
|
|
|
|
negative regulation of planar cell polarity pathway involved in neural tube closure
|
GO:2000168 |
1 |
0.206
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.206
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.206
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.199
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.190
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.183
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.177
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.171
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.163
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.162
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.158
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.156
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.153
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.151
|
|
|
|
regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:2000150 |
1 |
0.141
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.131
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.130
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.127
|
|
|
|
receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport
|
GO:0090118 |
1 |
0.126
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.126
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.125
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.119
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.117
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.117
|
|
|
|
regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000586 |
2 |
0.116
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.111
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.108
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.107
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.107
|
|
|
|
regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000159 |
1 |
0.107
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.107
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.103
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.102
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.100
|
|
|
|
canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development
|
GO:0061310 |
1 |
0.098
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.095
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.094
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.094
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.090
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.088
|
|
|
|
negative regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000160 |
1 |
0.087
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.087
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.086
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.085
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.083
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.083
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.083
|
|
|
|
histone h3 k9 acetylation
|
GO:0043970 |
5 |
0.083
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.082
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.082
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.082
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.080
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.079
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.079
|
|
|
|
regulation of planar cell polarity pathway involved in neural tube closure
|
GO:2000167 |
1 |
0.079
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.079
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.078
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.077
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.077
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.076
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.076
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.075
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.075
|
|
|
|
positive regulation of presynaptic membrane organization
|
GO:1901631 |
1 |
0.075
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.075
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.074
|
|
|
|
regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000165 |
1 |
0.074
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.073
|
|
|
|
canonical wnt signaling pathway involved in neural crest cell differentiation
|
GO:0044335 |
1 |
0.073
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.072
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.071
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.071
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.071
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.071
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.070
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.069
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.068
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.068
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.068
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.068
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.067
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.067
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.067
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.066
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.066
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.065
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.065
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.064
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.064
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.063
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.063
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.063
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.062
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.062
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.060
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:2000151 |
1 |
0.060
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.059
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.059
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.059
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.059
|
|
|
|
memory
|
GO:0007613 |
58 |
0.058
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.057
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.056
|
|
|
|
external genitalia morphogenesis
|
GO:0035261 |
1 |
0.056
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.056
|
|
|
|
wnt signaling pathway involved in somitogenesis
|
GO:0090244 |
4 |
0.055
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.055
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.054
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.054
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.054
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.053
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.052
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.052
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.052
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.052
|
|
|
|
extracellular matrix cell signaling
|
GO:0035426 |
5 |
0.051
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.051
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.051
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.050
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.050
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.050
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.050
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.050
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.050
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.050
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.049
|
|
|
|
response to folic acid
|
GO:0051593 |
2 |
0.049
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.048
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.048
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.048
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.048
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.048
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.047
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.047
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.047
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.047
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.047
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.046
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.046
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.046
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.045
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.045
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.045
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.044
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.044
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.043
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.043
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.042
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.042
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.042
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.041
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.041
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.041
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.041
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.041
|
|
|
|
energy homeostasis
|
GO:0097009 |
15 |
0.041
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.040
|
|
|
|
regulation of transcription from rna polymerase ii promoter by galactose
|
GO:0000431 |
1 |
0.040
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.040
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.040
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.039
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.039
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.039
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.039
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.039
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.038
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.038
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.038
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.038
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.038
|
|
|
|
hindbrain radial glia guided cell migration
|
GO:0021932 |
12 |
0.038
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.037
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.037
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.037
|
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.036
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.036
|
|
|
|
positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000060 |
8 |
0.036
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.036
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.036
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.036
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.036
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.036
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.035
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.035
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.035
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.035
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.035
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.034
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.034
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.034
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.034
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.033
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.033
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.033
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.033
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.033
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.033
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.033
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.033
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.032
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.032
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.032
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.032
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.032
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.031
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.031
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.030
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.030
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.030
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.030
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.030
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.030
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.030
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.029
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.029
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.029
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.029
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.029
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.029
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.029
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.029
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.029
|
|
|
|
negative regulation of non canonical wnt signaling pathway
|
GO:2000051 |
5 |
0.029
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.029
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.029
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.029
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.028
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.028
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.028
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.028
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.028
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.028
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.028
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.028
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.028
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.028
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.028
|
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.027
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.027
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.027
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.027
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.027
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.027
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.027
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.027
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.027
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.027
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.027
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.027
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.027
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.027
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.026
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.026
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.026
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.026
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.026
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.026
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.025
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.025
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.025
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.025
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.025
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.025
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.025
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.025
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.024
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.024
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.024
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.024
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.024
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.024
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.024
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.024
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
8 |
0.023
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.023
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.023
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.023
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.023
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.023
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.023
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.023
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.022
|
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.022
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.022
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.022
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
21 |
0.022
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.022
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.022
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.022
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.022
|
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
6 |
0.022
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.022
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.021
|
|
|
|
cell cell signaling involved in mammary gland development
|
GO:0060764 |
2 |
0.021
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000058 |
14 |
0.021
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.021
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.021
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.021
|
|
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.021
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.021
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.021
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.021
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.021
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.020
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.020
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.020
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.020
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.020
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.020
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.020
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.020
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.020
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.020
|
|
|
|
regulation of transcription by galactose
|
GO:0000409 |
1 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.020
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.020
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.020
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.020
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.020
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.020
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.019
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.019
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.019
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.019
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.019
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.019
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.019
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.019
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.019
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.019
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.019
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.019
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.019
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.019
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.019
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.019
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.019
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.019
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.019
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.018
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.018
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.018
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.018
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.018
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.018
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.018
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.018
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
genitalia morphogenesis
|
GO:0035112 |
11 |
0.018
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.018
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.018
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.018
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.018
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.018
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.018
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.017
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.017
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.017
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.017
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.017
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.017
|
|
|
|
regulation of cell proliferation involved in outflow tract morphogenesis
|
GO:1901963 |
2 |
0.017
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.017
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.017
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.017
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.017
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.016
|
|
